Inflammatory Bowel Disease (IBD) Research Symposium

Friday, Oct. 19, 2018

The Hershey Lodge
Empire A and B
325 University Dr.
Hershey, PA 17033


Select this button to navigate the sections of this page

Conference ID

J6345-19-Y

Purpose

The purpose of this event is to promote awareness and collaboration between scientists and clinicians.

Objectives

  • Discuss research at Penn State College of Medicine
  • Build collaborations
  • Develop pilot projects using Penn State Health Milton S. Hershey Medical Center’s IBD BioBank

Credit

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Using AMA Credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in 5.75 hours of approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing website.

Agenda

7:30 a.m. to 3:50 p.m.

  • 7:30 a.m. | Check-In/Continental Breakfast/Exhibitors
  • 8 a.m. | Opening Remarks
    Matthew Coates, MD, PhD, and Gregory S. Yochum, PhD
  • 8:15 a.m. | Penn State Health Milton S. Hershey Medical Center’s IBD BioBank
    Walter A. Koltun, MD, FACS, FASCRS
  • 8:35 a.m. | Expression of Tristetraprolin in the Intestinal Epithelium Exacerbates Dextran Sulfate Sodium (DSS) Colitis and Represses iNOS Expression
    Melanie Eshelman
  • 8:55 a.m. | Crohn’s Disease Associated SNP, rs6651252, Demarcates a Wnt-Responsive DNA Element in Intestinal Epithelial Cells
    Stephen Matthews, BS
  • 9:15 a.m. | Potential Role of a Voltage-Gated Sodium Channel in Silent Inflammatory Bowel Disease
    Matthew Coates, MD, PhD
  • 9:35 a.m. | Break/Exhibitors
  • 9:45 a.m. | Autophagy-Mediated Enhancement of Intestinal Tight Junction Barrier
    Prashant Nighot, PhD
  • 10:05 a.m. | Proton Pump Inhibitor (PPI)-Induced Colonic Tight Junction Barrier Dysfunction
    Meghali Nighot, PhD
  • 10:25 a.m. | Matrix Metalloproteinase-9 (MMP-9) Modulation of intestinal Tight Junction Permeability: Role of Myosin Light Chain Kinase
    Rana Al-Sadi, PhD
  • 10:45 a.m. | Break/Exhibitors
  • 11 a.m. | Keynote: Probiotic Targeting of Intestinal Tight Junction Barrier to Treat Inflammatory Bowel Disease
    Thomas Ma, MD, PhD
  • 11:45 a.m. | Lunch/Exhibitors
  • 1 p.m. | Using Transcriptomics to Understand the Pathophysiology of Ulcerative Colitis (UC)
    Gregory S. Yochum, PhD
  • 1:20 p.m. | Genetic Analysis of Ileocolic Crohn’s Disease
    Bryan Kline, MD
  • 1:40 p.m. | A Single Nucleotide Polymorphism in Dopamine Beta Hydroxylase (rs6271(C>T)) is Over-Represented in Inflammatory Bowel Disease Patients and Alters Protein Expression/Activity
    Eugene Gonzalez-Lopez, MS
  • 2 p.m. | Recent Advances on the Impact of Dietary Phytochemicals on Gastrointestinal Inflammation
    Joshua D. Lambert, PhD
  • 2:20 p.m. | Break/Exhibitors
  • 2:30 p.m. | The Clot Thickens: Venous Thromboembolism in Inflammatory Bowel Disease
    Andrew Tinsley, MD, MS
  • 2:50 p.m. | Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease
    Seyedehsan Navabi, MD
  • 3:10 p.m. | Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients with Ileal Pouch-Anal Anastomosis
    Subhash Gorrepati, MD, MPH
  • 3:30 p.m. | Characterization of the Silent Inflammatory Bowel Disease Patient
    Christopher Soriano, MD
  • 3:50 p.m. | Closing Remarks/Adjournment

Faculty

Rana Al-Sadi, PhD
Assistant Professor of Medicine
Gastroenterology
Penn State College of Medicine

Matthew Coates, MD, PhD
Assistant Professor of Medicine
Gastroenterology and Hepatology
Penn State College of Medicine

Melanie Eshelman
Graduate Student
Department of Biochemistry and Molecular Biology
Penn State College of Medicine

Eugene Gonzalez-Lopez, MS
Doctoral Student
Penn State College of Medicine

Subhash Gorrepati, MD, MPH
Fellow
Gastroenterology
Penn State Health Milton S. Hershey Medical center

Bryan Kline, MD
General Surgery Resident
Colorectal Surgery
Penn State Health Milton S. Hershey Medical center

Walter A. Koltun, MD, FACS, FASCRS
Professor of Surgery
Director, Penn State IBD Center
Chief, Colon and Rectal Surgery
Peter and Marshia Carlino Chair in IBD
Penn State College of Medicine

Joshua D. Lambert, PhD
Associate Professor
Department of Food Science
Penn State University Park
Penn State College of Agricultural Sciences

Thomas Ma, MD, PhD
Professor of Medicine
Cellular and Molecular Physiology and Microbiology and Immunology
Chair, Department of Medicine
J. Lloyd Huck Chair in Medicine
Gastroenterology
Penn State College of Medicine

Stephen Matthews, BS
Graduate Student
Department of Biochemistry and Molecular Biology and Surgery
Colon and Rectal Surgery
Penn State College of Medicine

Seyedehsan Navabi, MD
Fellow
Gastroenterology and Hepatology
Penn State Health Milton S. Hershey Medical center

Meghali Nighot, PhD
Assistant Professor of Medicine
Gastroenterology and Hepatology
Penn State College of Medicine

Prashant Nighot, PhD
Associate Professor of Medicine
Gastroenterology and Hepatology
Penn State College of Medicine

Christopher Soriano, MD
Resident Physician
Internal Medicine
Penn State Health Milton S. Hershey Medical center

Andrew Tinsley, MD, MS
Assistant Professor of Medicine
Gastroenterology and Hepatology
Associate Director, Penn State IBD Center
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Gregory S. Yochum, PhD
Associate Professor of Medicine
Department of Biochemistry and Molecular Biology and Surgery
Penn State College of Medicine

Fee

There is no fee for this program, but registration is required.

Cancellation

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund registration fees but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies. Preregistered participants will be notified if a program is filled or canceled.

Sponsor

This program is a continuing education service of Penn State College of Medicine and Penn State Inflammatory Bowel Disease Center.

Access (ADA)

Penn State encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of special accommodation or have questions about the physical access provided, please contact Continuing Education at least one week in advance of your participation or visit.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

Disclosure and Conflict of Interest (COI and educational balance)

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission, and employment without regard to personal characteristics not related to ability, performance, or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity, or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment, or retaliation against faculty, staff, or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; tel 814-863-0471/TTY. US M.Ed. J6345-19-Y

Jump to ...